Accuracy of CADx System for White Light Colonic Polyp Characterization
GIC
Accuracy and Feasibility of CADx System for White Light Colonic Polyp Characterization
1 other identifier
observational
500
1 country
1
Brief Summary
The endoscopist performances in the optical diagnosis (OD) of colonic polyps with the available technologies vary widely across centers and across endoscopists. The OD process is strictly related to the operator training and expertise. Most of the available studies in optical characterization have been carried out by expert endoscopist in tertiary high volume centers, and weren't replied on large unselected populations. For these reasons, at the moment the optical characterization of polypoid lesions can't replace, in the everyday clinical practice, the histopathological evaluation of resected polyps. Artificial intelligence (AI)-based systems have the potential to make optical characterization process of colonic polyps easier and more reliable, thus supporting the endoscopist in the application of leave-in-situ and of resect-and-discard strategies. The implementation of such strategies would lead to a significant economic saving and a decrease of risks and complications related to unnecessary polypectomy. GI-Genius System (Medtronic Inc, Minneaopolis, USA) is a CNN-based algorithm allowing an automatic OD of colonic polyps. This system does not require dedicated light setting for polyp evaluation as it works with white light high definition images, which are the actual standard in every endoscopic unit. During colonoscopy, when a polyp is framed within the screen, a green detection box surrounds the polyp and the system automatically provides (whenever possible) the optical diagnosis labeling the polyp as "adenoma or non-adenoma". When the automatic polyp charaterization is unfeasible the label "no prediction" appears. Nowadays only few data about the feasibility and performances of this system in clinical practice are available. In addition published studies are mostly focused on technical rather thann clinical issues. The present prospective observational trial is primarily aimed at evaluating the diagnostic accuracy of optical characterization of colonic polyps \<= 1 cm using GI-Genius System in daily clinical practice, having histopathology examination as reference standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2022
CompletedStudy Start
First participant enrolled
August 5, 2022
CompletedFirst Posted
Study publicly available on registry
August 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2022
CompletedMarch 26, 2024
March 1, 2024
3 months
August 5, 2022
March 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of CADx in evaluating small colonic polyps
Numer of correctly characterized polyps using AI/total number of detected polyps
Entire study duration (3 months)
Secondary Outcomes (5)
Feasibility of CADx in evaluating small colonic polyps
Entire study duration (3 months)
Sensitivity
Entire study duration (3 months)
specificity
Entire study duration (3 months)
Positive predictive value
Entire study duration (3 months)
Negative predictive value
Entire study duration (3 months)
Eligibility Criteria
Consecutive adults (18-85 years) outpatients referred for colonoscopy are invited to participate in the present study.
You may qualify if:
- Consecutive outpatients undergoing colonoscopy for one of the following indication:
- FIT-based screening program
- voluntary screening
- post-polipectomy surveillance
- gastrointestinal symptoms
- family history of colorectal cancer.
You may not qualify if:
- urgent colonoscopy
- patients in which polyps could not be resected (e.g ongoing anticoagulation therapy)
- patients with past colorectal cancer or polyposis syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Valduce Hospitallead
Study Sites (1)
Gastroenterology Unit, Valduce Hospital
Como, 22100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Gastroenterology Unit
Study Record Dates
First Submitted
August 5, 2022
First Posted
August 8, 2022
Study Start
August 5, 2022
Primary Completion
November 5, 2022
Study Completion
November 5, 2022
Last Updated
March 26, 2024
Record last verified: 2024-03